X

pharmaceuticals

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q1 2023 results

Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The…

Ocean Biomedical reports new results validating tumor suppression with anti-Chi3L1 antibody: EF Hutton raises OCEA price target to $17

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said its scientific co-founder Jack Elias published new findings in Cancer Research,…

ABBV Infographic: AbbVie’s Q1 2023 earnings and revenue decline

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a decrease in first-quarter 2023 adjusted earnings and revenues. The company also provided…

Eli Lilly and Company (LLY) Q1 2023 Earnings Call Transcript

Eli Lilly and Company (NYSE: LLY) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Joe Fletcher -- Senior…

BioMarin Pharmaceutical Inc (BMRN) Q1 2023 Earnings Call Transcript

BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Traci McCarty -- Group Vice President, Investor…

Everything you need to know about Biogen’s (BIIB) Q1 2023 earnings

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the first quarter of…

Ocean Biomedical co-founder Jonathan Kurtis presents detailed data on malaria vaccine at conference

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Rite Aid Corporation (RAD) Q4 2023 net loss narrows

Drugstore chain Rite Aid Corporation (NYSE: RAD) announced fourth-quarter 2023 results, reporting a modest increase in revenues and a narrower…

Intuitive Surgical (ISRG) looks poised for a strong year ahead

The healthcare industry has been witnessing an increase in demand for robotic-assisted surgical procedures due to their high efficiency and…

Intuitive Surgical (ISRG) Q1 adj. profit and revenue increase

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the first quarter of 2023, reporting higher revenues…

Infographic: Highlights of Abbott Laboratories’ Q1 2023 results

Healthcare company Abbott Laboratories (NYSE: ABT) announced financial results for the first quarter of 2023, reporting a decline in net…

JNJ Earnings: All you need to know about Johnson & Johnson’s Q1 2023 earnings results

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2023 earnings results today. Reported sales increased 5.6% year-over-year to $24.7 billion.…

Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…

Ocean Biomedical gets Notice of Allowance for US patent application for developing new malaria therapeutics

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a…

Key factors to consider before investing in Abbott Laboratories (ABT)

Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues…

CVS Health Corporation (CVS) bets big on primary care. What future holds

Retail pharmacy chain CVS Health Corporation (NYSE: CVS) has been diversifying with the aim of tapping into emerging opportunities, while…

Walgreens Boots Alliance Inc (WBA) Q2 2023 Earnings Call Transcript

Walgreens Boots Alliance Inc (NASDAQ:WBA) Q2 2023 Earnings Call dated Mar. 28, 2023. Corporate Participants: Tiffany Kanaga -- Vice President, Global Investor…

ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%

AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues…

TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel

TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including…

Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022.…